Elekta (OTCMKTS:EKTAY) Shares Gap Down – Should You Sell?

Elekta AB (OTCMKTS:EKTAY)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $6.63, but opened at $5.83. Elekta shares last traded at $5.7020, with a volume of 4,045 shares trading hands.

Elekta Trading Down 14.9%

The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95. The company has a 50 day moving average of $6.02 and a two-hundred day moving average of $5.98. The stock has a market cap of $2.08 billion, a PE ratio of -563.44 and a beta of 1.01.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. Elekta had a positive return on equity of 12.84% and a negative net margin of 0.08%. Sell-side analysts anticipate that Elekta AB will post 0.39 earnings per share for the current fiscal year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.